Here are the Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
Elevated remnant cholesterol, elevated blood remnant cholesterol triglyceride, elevated blood remnant cholesterol chart, elevated blood remnant cholesterol normal range, elevated blood remnant cholesterol and alzheimer s.
Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity
The connection between triglyceride-rich lipoproteins and cardiometabolic multimorbidity, characterized by the concurrence of at least two of type 2 diabetes, ischemic heart disease, and stroke, has not been definitively established. We aim to examine the prospective associations between serum remnant cholesterol, triglycerides, and the risks of progression from first cardiometabolic disease to multimorbidity via multistate modeling in the UK Biobank. We also evaluate the causality of these associations via Mendelian randomization using 13 biologically relevant SNPs as the genetic instruments. Here we show that elevated remnant cholesterol and triglycerides are significantly associated with gradually higher risks of cardiometabolic multimorbidity, particularly the progression of ischemic heart disease to the multimorbidity of ischemic heart disease and type 2 diabetes. These results advocate for effective management of remnant cholesterol and triglycerides as a potential stra tegy in mitigating the risks of cardiometabolic multimorbidity. © The Author(s) 2024.
Authors : Zhao Y.; Zhuang Z.; Li Y.; Xiao W.; Song Z.; Huang N.; Wang W.; Dong X.; Jia J.; Clarke R.; Huang T.
Source : Nature Research
Article Information
| Year | 2024 |
| Type | Article |
| DOI | 10.1038/s41467-024-46686-x |
| ISSN | 20411723 |
| Volume | 15 |
You can download the article here
If You have any problem, contact us here